Search results
Showing 51 to 100 of 8904 results
Suggest a topic for our prioritisation process
Home Get involved...
Home Get involved...
Home Get involved People and communities - putting you at the heart of our work {"@context":"http://schema.org","@type":"BreadcrumbList","itemLis
Home Get involved People and communities - putting you at the heart of our work {"@context":"http://schema.org","@type":"BreadcrumbList","itemLis
NICE International enquiry form
Keeping GPs and others working in primary care up-to-date with important developments.
Contact NICE Advice. We'll then give you an indication of how we can support you. In most cases, we'll include estimated costs and timelines sent straight to your inbox.
Home What NICE does Our guidance...
Home Get involved...
Home Get involved...
Permission to use NICE content for artificial intelligence (AI) purposes
Home Reusing our content Use of our content for AI purposes...
Home Reusing our content...
Home Reusing our content...
Permission request for international use of NICE content
NICE content assurance service
The key stages in development of our quality standards
New hope for people with breathing condition, COPD, as NICE approves innovative treatment
Breakthrough therapy reduces flare-ups by almost a third and could ease pressure on NHS hospitals.
Our guidelines make evidence based, best practice recommendations. These help to improve patient safety and reduce the risk of harm across the health system.
Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.
Thousands could benefit from new take-at-home treatment for advanced prostate cancer
NICE recommends life-extending daily pill which offers hope for people who cannot take standard treatment.
Online help programme recommended for people with eating disorders
An online therapy programme can be used to help people aged 16 and over with eating disorders whilst they wait for specialist NHS treatment, an independent NICE has said.
NICE is unable to make a recommendation on depemokimab (Exdensur) for treating chronic rhinosinusitis with nasal polyps in adults. This is because the company did not provide an evidence submission.
Show all sections
Sections for TA1123
Evidence-based recommendations on balloon cryoablation for Barrett's oesophagus. This involves freezing and destroying the abnormal cells using a balloon inflated with very cold gas.
Digital self-help for eating disorders: early value assessment (HTG768)
Early value assessment (EVA) guidance on digital self-help for eating disorders.
Early value assessment (EVA) guidance on digital technologies for managing mild to moderate symptoms of hip or knee osteoarthritis.
Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.
Thousands living with lupus offered hope from twice-yearly infusion
NICE approves breakthrough combination treatment that restores normal kidney function in almost half of patients with lupus nephritis.
Evidence-based recommendations on amivantamab (Rybrevant) with lazertinib (Lazcluze) for untreated EGFR mutation-positive advanced non-small-cell lung cancer in adults.
Day-to-day decision making is the responsibility of NICE's executive team.
Membership details, terms of reference, future meeting dates and past meeting minutes for our diagnostics advisory committee.
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
Biographies for all current members of the diagnostics advisory committee.
Biographies for all current members of the diagnostics advisory committee.
People and communities - putting you at the heart of our work
NICE is committed to involving people who use services, carers and the public in the development of our guidance and other products.
People and communities - putting you at the heart of our work
NICE is committed to involving people who use services, carers and the public in the development of our guidance and other products.
Home About us Executive team...
Policies, procedures, reports and codes of practice relating to the governance of NICE.
Acoramidis for treating transthyretin amyloidosis with cardiomyopathy (TA1121)
Evidence-based recommendations on acoramidis (Beyonttra) for treating wild-type or hereditary transthyretin amyloidosis with cardiomyopathy in adults.
NICE makes 4 types of recommendation that allow us to produce clear, directive, actionable guidance that is easy to understand and put into practice.
Hidden spine fractures could be spotted earlier after NICE recommendation
NICE is recommending that quick spine checks are added to routine bone scans to help spot hidden fractures earlier and prevent serious complications.
This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that may suggest cancer.
Show all sections
Sections for NG12
How to register with us as a medical technologies stakeholder.
How to register with us as a medical technologies stakeholder.
How to register with us as a diagnostic technologies stakeholder.
How to register with us as a diagnostic technologies stakeholder.
Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.
Our Medical Technologies Evaluation Programme (MTEP) considers technologies that could offer benefits to patients and the health and social care system over current practice.
Tell us about an interventional procedure you think should be assessed by NICE.
We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.